Photos are for display purposes only and may not reflect the actual product
Published human lactation studies for semaglutide are sparse, though animal reproduction studies showed no developmental toxicity
Cirne F, Kappel C, Zhou S, Mukherjee SD, Dehghan M, Petropoulos J-A, et al
Given the rapid increase in semaglutide use and its possible licensing for a range of problems other than obesity and type 2 diabetes, this issue deserves further study, but possible drug side-effects always need to be balanced against likely benefits. Semaglutide under the brand name Wegovy has been prescribed for weight loss on the NHS since 2023
Nature 642 , 9298 (2025)
While we offer a variety of weight loss medications, what sets us apart is the coaching and accountability we provide as part of your personalized, medically supervised plan